Skip to content
Trial Eligibility
Menu

Dose Escalation Study of Vinpocetine in Healthy Volunteers

NCT06635746

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The objective of this study is to determine whether vinpocetine is safe when taken at higher doses.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Fetal Alcohol Spectrum Disorders

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
18 to 40 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Stanford University
Last updated on ClinicalTrials.gov
November 19, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Stanford University · Palo Alto, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.